Nonetheless, our analysis indicated that the ROM benefit of intravenous dexamethasone on POD3 did not reach statistical significance when compared with the control group ( P = 0.24), suggesting that the advantageous effects of dexamethasone on ROM may wane from POD3 onwards.
← all excerpts
A systematic review and meta-analysis on the effects of intravenous dexamethasone on postoperative outcomes in patients undergoing total knee arthroplasty.
1
0.2400
0.2400